The role of intensive care nurses in cellular treatments during the COVID‐19 pandemic

Author:

Caliskan Figen1ORCID,Ozdemir Irem Nur2ORCID,Zeydan Ayten3ORCID,Kandemir Canan3ORCID,Yilmaz Rabia3ORCID,Karaoz Erdal456ORCID,Adas Gokhan Tolga78ORCID

Affiliation:

1. Nursing Department Trakya University, Health Sciences Faculty, Nursing Education Edirne Turkey

2. Department of Research and R&D, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Health Science University Istanbul Turkey

3. Department of Anesthesia and Intensive Care, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Health Science University Istanbul Turkey

4. Center for Stem Cell and Tissue Engineering Research & Practice Istinye University Istanbul Turkey

5. Faculty of Medicine, Department of Histology & Embryology Istinye University Istanbul Turkey

6. Center for Regenerative Medicine and Stem Cell Manufacturing (LivMedCell) Liv Hospital Istanbul Turkey

7. Department of Surgery, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Health Science University Istanbul Turkey

8. Head of Stem Cell and Gene Therapies Application and Research Center Health Science University Istanbul Turkey

Abstract

AbstractBackgroundToday, the use of cellular therapies as an effective treatment in the field of health is increasing. In the COVID‐19 pandemic or similar situations, cellular therapies may be sometimes life‐saving. The COVID‐19 pandemic has shown us that the training of intensive care nurses in special cases, such as cellular therapies, is insufficient.AimThe study aimed to determine the duties, responsibilities and training of intensive care nurses on mesenchymal stem cells (MSCs) transplantation to critically ill patients during the COVID‐19 pandemic.Study DesignThis descriptive and retrospective study was conducted on 107 critically ill patients diagnosed with COVID‐19 infection and followed up in the intensive care unit (ICU) between April 2020 and April 2022. Each patient was transplanted MSCs by intravenous infusion three times. Before starting cellular therapy applications, intensive care nurses were selected to work on this treatment modality. Each nurse was given theoretical and practical training by experienced instructors.ResultsIntensive care nurses trained for MSCs transplants took part in the pre‐application, preparation, application and post‐application period. MSCs were checked by the ICU nurses in the pre‐application period. Patients' vital signs, existing catheters, consciousness status and parameters were checked by nurses in the preparation and application period. No side effects and complications were observed in patients during MSCs transplantation and within the first 24 h. Patients' late complications and mortality were recorded by nurses during the post‐application periods.ConclusionsWe recommend that nurses working especially in Level 3 ICUs receive training and certification in cellular therapies, especially in hospitals where advanced/cellular treatments are applied.Relevance to Clinical PracticeIntensive care nurses are actively involved in every phase of the application of MSCs. Especially before such special practices, which came to the fore with the COVID‐19 pandemic, training should be organized for intensive care nurses.

Publisher

Wiley

Subject

Critical Care Nursing

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3